In late September 2024, Hurricane Helene hit Florida and then quickly made her way up into Georgia before moving over the southern Appalachians. In eastern Tennessee and North Carolina, Hurricane Helene caused historic flooding and widespread devastation.

Loren Bonner

HHS has the authority to exclude pharmacists who have been convicted of controlled substance violations from working in any facility that receives payment from Medicare, Medicaid, or any other federally funded health care program.

David B. Brushwood, BSPharm, JD

An estimated 57,997 people in the United States died from a fentanyl overdose between September 2023 and August 2024.

Sonya Collins

Do health care providers need to standardize their approach when educating patients on home BP measurement? Based on their findings, authors of a research article in the January 2025 issue of the  American Heart Association’s (AHA) journal think so.

Olivia C. Welter, PharmD

What are the specific reasons for patients not receiving necessary vaccinations?

Cristian Rodriquez, PharmD

Patients now have the choice of two different automated insulin delivery (AID) systems for the treatment of T2D after the results of a control group study published in NEJM on March 19, 2025, further demonstrated the benefits of AID systems in treating T2D.

Kevin Willmann

In April 2025, FDA issued an alert to health care providers, compounders, and consumers about potential risks associated with compounded topical finasteride products. The alert was issued after FDA was made aware of adverse events involving these products, which are not FDA-approved.

Lauren Howell, PharmD

Sulfonylureas are high risk for older adults due to the possibility of hypoglycemia. A clinical pharmacist intervention achieved a 41% deprescribing rate of sulfonylureas in older adult patients in a managed care setting, according to study results published March 15, 2025, in JAPhA.

Jen Hand

GLP-1 receptor agonists like semaglutide (Ozempic) have transformed the management of T2D and obesity. However, their increasing use has introduced new challenges in other areas of clinical care, including GI procedures.

Sonya Collins

Camu camu supplements are touted as a potent immune boost, supporting overall wellness and skin health.

Mickie Cathers

Dry mouth, also known as xerostomia, occurs when insufficient saliva is produced to keep the mouth moist.

Mary Warner

Updates from FDA

APhA Staff

AFib with rapid ventricular response (RVR) is often treated with diltiazem, a nondihydropyridine calcium channel blocker.

APhA Staff

Artificial intelligence (AI) is no longer “on the horizon” in health care. It’s becoming an active partner in patient care, including in health-system pharmacies.

Sonya Collins

As anyone who has helped an aging parent maintain their regimen of prescriptions knows, keeping track of timing, interaction risks, and adverse effects can be a dizzying task.

Elizabeth Briand

As coronary artery calcium (CAC) testing becomes more accessible, questions around its clinical utility are becoming more nuanced.

Aiya Almogaber, PharmD

Metformin—one of the most frequently prescribed medications on the planet—is considered the first-line treatment for T2D with an estimated 20 million individuals taking it each day in the United States alone.

Elizabeth Briand

Chronic kidney disease (CKD) affects millions globally and presents significant challenges in diagnosis, management, and longterm care planning.

Corey Diamond, PharmD

An estimated 30.6 million adults in the United States will use benzodiazepines within the past year. Benzodiazepines are prescribed for a wide range of conditions, including anxiety, insomnia, muscle spasms, anesthesia, catatonia, status epilepticus, and withdrawal from alcohol or benzodiazepines.

Thao Anh Mai, PharmD; Kami Johnston, PharmD; Jeffrey D. Gold, PharmD, BCPP

APhA Member News

APhA staff

Take the Crossword Challenge